These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 17548632

  • 1. Episodes of natural selection shaped the interactions of IgA-Fc with FcalphaRI and bacterial decoy proteins.
    Abi-Rached L, Dorighi K, Norman PJ, Yawata M, Parham P.
    J Immunol; 2007 Jun 15; 178(12):7943-54. PubMed ID: 17548632
    [Abstract] [Full Text] [Related]

  • 2. Structural basis for evasion of IgA immunity by Staphylococcus aureus revealed in the complex of SSL7 with Fc of human IgA1.
    Ramsland PA, Willoughby N, Trist HM, Farrugia W, Hogarth PM, Fraser JD, Wines BD.
    Proc Natl Acad Sci U S A; 2007 Sep 18; 104(38):15051-6. PubMed ID: 17848512
    [Abstract] [Full Text] [Related]

  • 3. The staphylococcal superantigen-like protein 7 binds IgA and complement C5 and inhibits IgA-Fc alpha RI binding and serum killing of bacteria.
    Langley R, Wines B, Willoughby N, Basu I, Proft T, Fraser JD.
    J Immunol; 2005 Mar 01; 174(5):2926-33. PubMed ID: 15728504
    [Abstract] [Full Text] [Related]

  • 4. Interaction of human, rat, and mouse immunoglobulin A (IgA) with Staphylococcal superantigen-like 7 (SSL7) decoy protein and leukocyte IgA receptor.
    Wines BD, Ramsland PA, Trist HM, Gardam S, Brink R, Fraser JD, Hogarth PM.
    J Biol Chem; 2011 Sep 23; 286(38):33118-24. PubMed ID: 21784854
    [Abstract] [Full Text] [Related]

  • 5. Insights into IgA-mediated immune responses from the crystal structures of human FcalphaRI and its complex with IgA1-Fc.
    Herr AB, Ballister ER, Bjorkman PJ.
    Nature; 2003 Jun 05; 423(6940):614-20. PubMed ID: 12768205
    [Abstract] [Full Text] [Related]

  • 6. FcαRI binding at the IgA1 CH2-CH3 interface induces long-range conformational changes that are transmitted to the hinge region.
    Posgai MT, Tonddast-Navaei S, Jayasinghe M, Ibrahim GM, Stan G, Herr AB.
    Proc Natl Acad Sci U S A; 2018 Sep 18; 115(38):E8882-E8891. PubMed ID: 30181292
    [Abstract] [Full Text] [Related]

  • 7. The interaction of Fc alpha RI with IgA and its implications for ligand binding by immunoreceptors of the leukocyte receptor cluster.
    Wines BD, Sardjono CT, Trist HH, Lay CS, Hogarth PM.
    J Immunol; 2001 Feb 01; 166(3):1781-9. PubMed ID: 11160224
    [Abstract] [Full Text] [Related]

  • 8. FcalphaRI-positive liver Kupffer cells: reappraisal of the function of immunoglobulin A in immunity.
    van Egmond M, van Garderen E, van Spriel AB, Damen CA, van Amersfoort ES, van Zandbergen G, van Hattum J, Kuiper J, van de Winkel JG.
    Nat Med; 2000 Jun 01; 6(6):680-5. PubMed ID: 10835685
    [Abstract] [Full Text] [Related]

  • 9. A competitive mechanism for staphylococcal toxin SSL7 inhibiting the leukocyte IgA receptor, Fc alphaRI, is revealed by SSL7 binding at the C alpha2/C alpha3 interface of IgA.
    Wines BD, Willoughby N, Fraser JD, Hogarth PM.
    J Biol Chem; 2006 Jan 20; 281(3):1389-93. PubMed ID: 16293625
    [Abstract] [Full Text] [Related]

  • 10. Immunoglobulin A-mediated protection against Bordetella pertussis infection.
    Hellwig SM, van Spriel AB, Schellekens JF, Mooi FR, van de Winkel JG.
    Infect Immun; 2001 Aug 20; 69(8):4846-50. PubMed ID: 11447159
    [Abstract] [Full Text] [Related]

  • 11. The Fc receptor for IgA (FcalphaRI, CD89).
    Otten MA, van Egmond M.
    Immunol Lett; 2004 Mar 29; 92(1-2):23-31. PubMed ID: 15081523
    [Abstract] [Full Text] [Related]

  • 12. The human immunoglobulin A Fc receptor FcαRI: a multifaceted regulator of mucosal immunity.
    Bakema JE, van Egmond M.
    Mucosal Immunol; 2011 Nov 29; 4(6):612-24. PubMed ID: 21937986
    [Abstract] [Full Text] [Related]

  • 13. IgA and FcαRI: Pathological Roles and Therapeutic Opportunities.
    Breedveld A, van Egmond M.
    Front Immunol; 2019 Nov 29; 10():553. PubMed ID: 30984170
    [Abstract] [Full Text] [Related]

  • 14. Anti-inflammatory role of the IgA Fc receptor (CD89): from autoimmunity to therapeutic perspectives.
    Ben Mkaddem S, Rossato E, Heming N, Monteiro RC.
    Autoimmun Rev; 2013 Apr 29; 12(6):666-9. PubMed ID: 23201915
    [Abstract] [Full Text] [Related]

  • 15. Signaling through mutants of the IgA receptor CD89 and consequences for Fc receptor gamma-chain interaction.
    Bakema JE, de Haij S, den Hartog-Jager CF, Bakker J, Vidarsson G, van Egmond M, van de Winkel JG, Leusen JH.
    J Immunol; 2006 Mar 15; 176(6):3603-10. PubMed ID: 16517729
    [Abstract] [Full Text] [Related]

  • 16. The era of the immunoglobulin A Fc receptor FcαRI; its function and potential as target in disease.
    Aleyd E, Heineke MH, van Egmond M.
    Immunol Rev; 2015 Nov 15; 268(1):123-38. PubMed ID: 26497517
    [Abstract] [Full Text] [Related]

  • 17. Expression and correlation analysis of IL-4, IFN-γ and FcαRI in tonsillar mononuclear cells in patients with IgA nephropathy.
    Chen X, Liu H, Peng Y, He L, Zhang Y, Xie Y, Peng X, Liu C, Liu F.
    Cell Immunol; 2014 Nov 15; 289(1-2):70-5. PubMed ID: 24732061
    [Abstract] [Full Text] [Related]

  • 18. Nonhuman primate IgA: genetic heterogeneity and interactions with CD89.
    Rogers KA, Jayashankar L, Scinicariello F, Attanasio R.
    J Immunol; 2008 Apr 01; 180(7):4816-24. PubMed ID: 18354205
    [Abstract] [Full Text] [Related]

  • 19. IgA Fc receptors.
    Monteiro RC, Van De Winkel JG.
    Annu Rev Immunol; 2003 Apr 01; 21():177-204. PubMed ID: 12524384
    [Abstract] [Full Text] [Related]

  • 20. IgA and the IgA Fc receptor.
    van Egmond M, Damen CA, van Spriel AB, Vidarsson G, van Garderen E, van de Winkel JG.
    Trends Immunol; 2001 Apr 01; 22(4):205-11. PubMed ID: 11274926
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.